The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.49
Bid: 6.02
Ask: 6.98
Change: 0.00 (0.00%)
Spread: 0.96 (15.947%)
Open: 6.49
High: 0.00
Low: 0.00
Prev. Close: 6.49
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Nov 2021 14:26

RNS Number : 0144T
Synairgen plc
19 November 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Synairgen PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Polygon Global Partners LLP

Reade Eugene Griffith

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.) v

Name

Aurora Nominee Ltd

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reached vi:

17/11/2021

6. Date on which issuer notified (DD/MM/YYYY):

19/11/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

15.571

0

15.571

31,350,000

Position of previous notification (if

applicable)

12.913

2.427

15.341

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00B0381Z20

0

31,350,000

0

15.571

SUBTOTAL 8. A

31,350,000

15.571%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Reade Eugene Griffith

15.571

0

15.571

Polygon Global Partners LLP

15.571

0

15.571

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Reade Eugene Griffith is the ultimate controlling natural person of Polygon Global Partners LLP, an investment manager which has investment discretion over certain funds and managed accounts.

 

Place of completion

London, United Kingdom

Date of completion

19 November 2021

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFFSLSLALIL
Date   Source Headline
8th Dec 20117:00 amRNSEnd of Recruitment in Phase II Asthma Trial
25th Nov 20117:00 amRNSPositive Viral Pneumonia Study Results
10th Nov 201112:40 pmRNSResult of AGM
18th Oct 20111:50 pmRNSNotice of AGM and posting of Annual Reports
22nd Sep 20113:10 pmRNSGrant of options
9th Sep 20117:00 amRNSChange of Adviser
18th Jul 20117:00 amRNSJapanese Patent to be Granted
28th Jun 20117:00 amRNSPhase II asthma study - Interim Review and update
15th Jun 20113:56 pmRNSHolding(s) in Company
13th Jun 201111:54 amRNSResult of General Meeting
27th May 20111:00 pmRNSFundraising
4th May 20117:00 amRNSAntiviral activity against Bird Flu
2nd Feb 201111:31 amRNSHolding(s) in Company
1st Feb 20117:00 amRNSHalf Yearly Report
3rd Nov 20101:35 pmRNSResult of AGM
19th Oct 20107:00 amRNSUS Patent
8th Oct 20109:00 amRNSNotice of AGM and Posting of Annual Report
9th Sep 20107:00 amRNSGrant of Options
29th Jul 20107:00 amRNSFinal Results
27th Jul 20107:00 amRNSNotice of Results
29th Jun 20107:00 amRNSGrant of Options
28th Jun 20107:00 amRNSDirectorate Change
17th May 20107:00 amRNSPositive Influenza Data
6th May 20107:00 amRNSIFN-beta Patent Granted in Europe
1st Apr 20107:00 amRNSPhase II Trials
24th Feb 20103:27 pmRNSHolding(s) in Company
8th Feb 20107:00 amRNSHalf Yearly Report
15th Jan 20107:00 amRNSHolding(s) in Company
12th Nov 20097:00 amRNSSuccessful Outcome of Phase 1 Study
11th Nov 20091:24 pmRNSResult of AGM
9th Nov 20097:00 amRNSactivity of interferon beta against swine flu
26th Oct 20097:00 amRNSNotice of Investor Conference
14th Oct 20092:35 pmRNSNotice of Annual Report and Accounts and AGM
8th Sep 200911:25 amRNSGrant of Options
4th Sep 20097:00 amRNSFinal Results
4th Sep 20097:00 amRNSUS Patent Granted
4th Sep 20097:00 amRNSDirectorate Changes
2nd Sep 20097:00 amRNSNotice of Results
17th Jul 20093:00 pmRNSHolding(s) in Company
30th Jun 20099:56 amRNSTotal Voting Rights
25th Jun 20092:36 pmRNSHolding(s) in Company
23rd Jun 20097:00 amRNSHolding(s) in Company
15th Jun 200911:06 amRNSSecond Closing of the Fundraising
12th Jun 200911:22 amRNSResult of General Meeting
27th May 20097:00 amRNSFundraising Announcement
1st Apr 20097:00 amRNSPreliminary biomarker data
31st Mar 20097:00 amRNSChange of Adviser
26th Mar 20097:00 amRNSHalf Yearly Results
24th Mar 200911:14 amRNSNotice of Results
17th Mar 20097:00 amRNSProgress update: Clinical Trial - Interferon Beta

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.